Insulin degludec/Insulin aspart（HEC）
德谷胰岛素/门冬胰岛素（东阳光）
Report date: 2025/06/17 16:48:28
Base Information
Drug NameInsulin degludec/Insulin aspart（HEC）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesDongguan City Hec Biological Medicine Res And Development Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesDongguan City Hec Biological Medicine Res And Development Co LtdYichang Hec Changjiang Pharmaceutical Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG